Can Wearables Detect Physiological Deterioration Before Symptoms?

Abstract

Consumer wearables can gather heart rate, movement, sleep estimates and in some devices temperature-related signals over long periods. Changes relative to baseline may precede recognized illness in selected contexts. This paper examines the benefits and pitfalls of applying anomaly detection to personal physiology and argues that actionable warning depends on specificity, sustained change and clinical context.

The Clinical Question and Its Context

Resting heart rate may rise during fever, stress, dehydration, poor sleep or certain medications. Reduced activity can be both a cause and consequence of illness. Sleep staging from consumer devices is an algorithmic estimate, not the equivalent of full polysomnography. Sensor characteristics vary across hardware versions and body placement; missing data are often not random because people remove devices when uncomfortable.

Proposed Biological or Explanatory Model

The conceptual opportunity lies in within-person deviations sustained across multiple modalities. A brief rise in heart rate after exercise should be treated differently from an unexplained multi-day shift accompanied by increased temperature and reduced recovery. However, even converging signals rarely identify a unique disease; they primarily indicate that something has changed. The system should separate general wellness alerts from urgent clinical warning signs.

Mechanism-Specific Interpretation

Wearable signals can shift in response to illness, but the most difficult part is deciding when a deviation becomes actionable. A nocturnal heart-rate elevation may reflect fever, alcohol, stress, dehydration, travel or poorly fitted sensors. Several changes occurring together may increase concern without identifying the disease. Because a user supplies many days of data, seemingly rare alerts can become common over a year. That creates a longitudinal false-discovery problem unlike a single clinic visit. Designs should incorporate sustained deviation, clinically relevant thresholds and the option for a neutral “watch and reassess” message rather than constant alarm.

Competing Explanations and Limits of Inference

False alarms can accumulate rapidly in continuously monitored populations, and excessive attention to daily variability may increase health anxiety. A classifier trained to flag infection may also respond to travel, alcohol, medication or menstrual changes. Demonstrating detection before reported symptoms is not equivalent to demonstrating fewer hospitalizations or better outcomes.

Discriminating Observations and Evidence Thresholds

Evidence for pre-symptomatic pattern changes is not evidence that automatic alerts improve outcomes. Validation should examine lead time, false-alert frequency per person-year, subgroup performance, adherence and clinical consequences. The safest model is an assistant to observation and medical triage, not a replacement for symptom evaluation or urgent medical care.

Implications for Interpretation and Future Inquiry

This paper provides a safety-aware framework for Apple Watch, Oura and comparable device integrations without implying any specific data connector or product validation. Its strongest insight is that personal baselines can increase signal relevance only when robust uncertainty management and confirmation pathways are built into the system.

Selected Evidence and Further Reading

These are selected primary studies, method papers or scientific reviews relevant to the argument, not a complete systematic bibliography. The evidence supplied is used to assess, not automatically establish, the proposed causal explanation.

1. Mishra et al. Pre-symptomatic detection of COVID-19 from smartwatch data
2. Quer et al. Wearable sensor data and self-reported symptoms for COVID-19 detection